Diabetes Education 공개
[search 0]

Download the App!

show episodes
 
The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The Am ...
 
Loading …
show series
 
Listen to Dr. Jennifer Green and Dr. Neha Pagidipati discuss the utilization of SGLT2i and GLP-1RA in the hospital setting in patients with indications for such therapy, as described in the 2021 ADA Standards of Medical Care and current AHA guidelines, including the recent ASA/AHA Recurrent Stroke prevention guidelines.…
 
Listen to George L. Bakris, MD, FAHA, FASN, Cecilia C. Low Wang, MD, FACP and Neda Rasouli, MD educate clinicians on the updates made in the 2021 ADA Standards of Care related to metformin use and considerations for when the guideline recommends considering use of SGLT-2 Inhibitors and GLP-1 receptor agonists independent of A1C or metformin use.…
 
Listen to Dr. Boris Draznin, an endocrinologist and specialist in diabetes and internal medicine, and Dr. Pam Kushner, a specialist in family medicine discuss how the new American Diabetes Association’s 2021 Standards of Care have changed and implications for practice.
 
Patients with T2D and CKD have a very high risk of CV events. Listen as Dr. Jorge Plutzky and Dr. Neha Pagidipati discuss new therapies to manage cardiovascular and renal risk in patients with T2D. Their discussion is based on new science presented during AHA Scientific Sessions 2020.
 
Listen as Dr. Eduardo Sanchez from the American Heart Association and Dr. Robert Gabbay from the American Diabetes Association discuss social determinants of health and disparities in health and health care in individuals with type 2 diabetes at risk for cardiovascular disease and COVID-19 and what can be done to improve their outcomes.…
 
Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) …
 
Listen to Dr. Jay Shubrook, DO, a primary care physician and Dr. Bankim Bhatt, MD, an adult endocrinologist discuss diabetes management, telemedicine, and lessons learned in the time of COVID-19.
 
Listen to members of the writing group for the new AHA statement on the clinical management of stable coronary artery disease in patients with T2D. Dr. Suzanne Arnold, Chair, and fellow writing group members, Dr. Prakash Deedwania and Dr. Mikhail Kosiborod will review highlights from the statement, including recent clinical trials which uncovered s…
 
People with type 2 diabetes and chronic kidney disease are at three times higher risk of dying from a cardiovascular event. According to the National Kidney Foundation, the two main causes of chronic kidney disease are diabetes and high blood pressure. These two conditions were the primary diagnosis in 75% of kidney failure cases between 2015-2017.…
 
Listen to Dr. Nancy Albert, a clinical nurse specialist and lead researcher in heart failure and Dr. Mikhail Kosiborod, a cardiologist and expert in the fields of diabetes, cardiovascular diseases, cardiometabolic and cardiorenal syndromes, and quality care and outcomes discuss heart failure management in patients with type 2 diabetes and cardiovas…
 
Studies on COVID-19 are revealing that patients diagnosed with COVID-19 and who have type 2 diabetes and history of cardiovascular disease are showing increased complications. Listen to Dr. Anne Peters, an endocrinology, diabetes and metabolism specialist and Dr. Diana Issacs, an endocrine clinical pharmacy specialist discuss tackling COVID-19 in t…
 
Goal setting and discussing lifestyle management with your patients is critical in managing the link between diabetes and heart disease. Listen to Dr. Nathanial Clark, an endocrinologist, and Melissa Magwire, a nurse and CDE (Certified Diabetes Educator) discuss how to initiate the conversation and set your patient up for success.…
 
In a recent survey of people age 45 and older with type 2 diabetes, conducted online by The Harris Poll, only half recognize their cardiovascular risk or have discussed their risk of heart attacks or strokes with their health care providers. Listen to cardiologist, Dr. Tracy Wang and endocrinologist, Dr. Robert Eckel discuss how a cardiologist can …
 
The management of type 2 diabetes to prevent cardiovascular disease has been focused on glycemic control and the use of drugs based on their ability to lower levels of glycemia. Listen to Dr. Robert Eckel and Dr. Chris Cannon discuss the use of anti-hyperglycemic agents with CVD benefits.
 
Diabetes education has positive effects not only on psychosocial and behavioral aspects of diabetes care, but also known to be a cost-effective treatment by reducing hospital readmissions and lowered risk for complications. Yet, many patients often do not receive DSMES (Diabetes Self-Management Education and Support) referrals. Listen to Nancy D’Ho…
 
Identifying and implementing optimal treatment strategies for patients living with diabetes and heart failure is critical to improving outcomes for this population. Shannon Dunlay, MD, MS discusses managing patients with diabetes who are at risk for heart failure or those that have heart failure. This podcast is based on the new scientific statemen…
 
The ASCVD Risk Calculator is a tool that enables healthcare providers and patients to estimate 10-year risk for atherosclerotic cardiovascular disease or ASCVD. Salim Virani, MD discusses the ASCVD risk calculator and why this assessment needs to be performed in patients with diabetes.
 
Shared decision-making is an effective approach to ensure patient and family involvement in decision-making and tailoring of treatment plans to meet goals. Jay Shubrook, DO, Robert Eckel, MD, and Patricia Montesinos, CRNP, CDE discuss how to interview and bring their patients to a collaborative discussion and joint treatment plan.…
 
For people with diabetes, blood glucose isn’t the only important factor to track. New guidelines suggest the more than 110 million U.S. adults with diabetes or prediabetes should also manage their cholesterol as well as their blood glucose. Drs. Ronald Goldberg and Robert Eckel discuss the new American Heart Association’s 2018 Cholesterol Guideline…
 
Christopher Cannon, MD and Ronald Goldberg, MD discuss the management and treatment of diabetes to prevent cardiovascular disease in the new American Diabetes Association’s 2019 Standards of Care.
 
Loading …

빠른 참조 가이드

Google login Twitter login Classic login